Filing Details

Accession Number:
0001493152-22-016226
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-06-09 06:04:33
Reporting Period:
2022-06-07
Accepted Time:
2022-06-09 06:04:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1574094 Renovorx Inc. RNXT Pharmaceutical Preparations (2834) 271448452
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1862617 Ramtin Agah C/O Renovorx, Inc.,
4546 El Camino Real, Suite B1
Los Altos, CA 94022
Chief Medical Officer Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-03-16 975,000 $0.00 1,295 No 5 G Direct
Common Stock Acquisiton 2022-03-16 975,000 $0.00 975,000 No 5 G Indirect See footnote
Common Stock Acquisiton 2022-06-07 5,182 $1.93 6,477 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Direct
No 5 G Indirect See footnote
No 4 P Direct
Footnotes
  1. The shares are held of record by the Mars16 Nevada Non-Grantor Trust Dtd 01/19/2016.